Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 4.15M | $99.0M | 7.13% | +723.2K | 2026-06-30 |
| Tang Capital Management LLC | 4.10M | $98.0M | 7.06% | +700.0K | 2026-06-30 |
| Montanova Capital, LLC | 4.09M | $98.0M | 7.04% | +274.2K | 2026-06-30 |
| State Street Corp | 3.40M | $81.0M | 5.85% | +1.22M | 2026-06-30 |
| Vanguard Capital Management LLC | 2.30M | $55.0M | 3.95% | +269.9K | 2026-06-30 |
| Goldman Sachs Group Inc | 1.58M | $38.0M | 2.72% | +666.2K | 2026-06-30 |
| Citadel Advisors LLC | 1.55M | $37.0M | 2.66% | +106.2K | 2026-06-30 |
| RA Capital Management, L.P. | 1.51M | $36.0M | 2.59% | -- | 2026-06-30 |
| Perceptive Advisors LLC | 1.50M | $36.0M | 2.58% | +1.26M | 2026-06-30 |
| Boxer Capital Management, LLC | 1.40M | $33.0M | 2.40% | +805.2K | 2026-06-30 |
